Relevance of estrogen and progesterone receptors enzyme immunoassay in malignant, benign and surrounding normal thyroid tissue

被引:30
作者
Bonacci, R
Pinchera, A
Fierabracci, P
Gigliotti, A
Grasso, L
Giani, C
机构
[1] Istituto di Endocrinologia, University of Pisa, Pisa
[2] Istituto di Endocrinologia, University of Pisa, 56018 Tirrenia Pisa
关键词
estrogen receptor; progesterone receptor; thyroid disease; thyroid carcinoma; enzyme-immunoassay;
D O I
10.1007/BF03349859
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Several authors have demonstrated the presence of estrogen receptors (ER) and progesterone receptors (PR) in thyroid tissue, generally using dextran coated charcoal method (DCCA). The aim of this study was to measure ER and PR in thyroid specimens using an immunoenzymatic method, and to evaluate the meaning of different prevalence of ER and PR in malignant and benign thyroid disease, as compared with normal thyroid tissue. We have measured ER and PR in thyroid tissue from 28 benign and 20 malignant thyroid lesions, and in 38 samples of surrounding normal thyroid tissues. The sensitivity of ER-EIA and PR-EIA was 1.0 and 1.5 fmol/mg protein, respectively. In thyroid carcinoma the frequency of ER positivity (ER+) was 7/20 (35%); it was significantly higher in the surrounding normal tissue (15/20;71%) (p=0.03). In benign thyroid disease, the prevalence of ER+ was 11/28 (39%) and in the surrounding normal tissue it was 11/18 (61%) (p-not significant), PR+ was detected in 7/20 (35%) thyroid cancers and in 15/28 (53%) benign lesions without significant difference with the frequency detected in the surrounding normal tissues. ER and PR concentrations (mean+/-SD) in thyroid cancer was 2.2+/-2.2 and 2.2+/-2.9 respectively, similarly to that detected in benign thyroid disease and in normal tissue. The simultaneous presence of ER and PR (ER+PR+) was also evaluated. We have found that the frequency of ER+ PR+ was significantly higher in benign lesions (8/28; 28.6%) as compared with malignant samples (1/20; 5%) (p<0.05); the frequency of ER+PR+ was significantly higher in normal tissue surrounding the malignant lesions (9/20;45) (p=0.003), Our data indicate i) EIA method is appropriate to detect ER and PR in thyroid tissue. ii) The frequency of ER+ and ER+PR+ specimens is significantly higher in normal thyroid tissue than in pathologic tissues. This indicates that ER and PR immunoassays may be useful tools to evaluate the normal biological activity of thyroid cells.
引用
收藏
页码:159 / 164
页数:6
相关论文
共 28 条
  • [1] DISTRIBUTION AND CHARACTERIZATION OF STEROID-HORMONE RECEPTORS IN HUMAN THYROID-TISSUE
    CHAUDHURI, PK
    PATEL, N
    SANDBERG, L
    PRINZ, RA
    [J]. WORLD JOURNAL OF SURGERY, 1986, 10 (05) : 737 - 744
  • [2] PROGESTERONE RECEPTORS AND HUMAN-BREAST CANCER
    CLARK, GM
    MCGUIRE, WL
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1983, 3 (02) : 157 - 163
  • [3] ESTROGEN AND THYROID-STIMULATING HORMONE (TSH) RECEPTORS IN NEOPLASTIC AND NONNEOPLASTIC HUMAN THYROID-TISSUE
    CLARK, OH
    GEREND, PL
    DAVIS, M
    GORETZKI, PE
    HOFFMAN, PG
    [J]. JOURNAL OF SURGICAL RESEARCH, 1985, 38 (02) : 89 - 96
  • [4] COMPARISON OF MONOCLONAL IMMUNOCYTOCHEMICAL AND IMMUNOENZYMATIC METHODS FOR STEROID-RECEPTOR EVALUATION IN BREAST-CANCER
    DENEGRI, F
    CAMPANI, D
    SARNELLI, R
    MARTINI, L
    GIGLIOTTI, A
    BONACCI, R
    FABBRI, R
    SQUARTINI, F
    PINCHERA, A
    GIANI, C
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1991, 96 (01) : 53 - 58
  • [5] DIAZ NM, 1991, ARCH PATHOL LAB MED, V115, P1203
  • [6] INTERFERENCE OF THYROPEROXIDASE ON IMMUNO-CYTOCHEMICAL DETERMINATION OF STEROID-RECEPTORS IN THYROID-TISSUE
    GIANI, C
    CAMPANI, D
    DENEGRI, F
    MARTINI, L
    FABBRI, R
    BONACCI, R
    CIANCIA, EM
    GIGLIOTTI, A
    FIERABRACCI, P
    PINCHERA, A
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1993, 16 (01) : 37 - 43
  • [7] GREENE GL, 1987, IMMUNOLOGICAL APPROA, P119
  • [8] BREAST-CANCER .3.
    HARRIS, JR
    LIPPMAN, ME
    VERONESI, U
    WILLETT, W
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (07) : 473 - 480
  • [9] HENDERSON BE, 1982, CANCER RES, V42, P3232
  • [10] INOUE H, 1993, CANCER, V72, P1364, DOI 10.1002/1097-0142(19930815)72:4<1364::AID-CNCR2820720435>3.0.CO